Gentamicin Sulfate Ophthalmic Solution USP Sterile Rx Only

Manufacturer
REMEDYREPACK INC.
Effective date
2024-01-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 21:15:42

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure11 sections

Indications and uses

Gentamicin Sulfate Ophthalmic Solution is indicated in the topical treatment of ocular bacterial infections, including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneu...

Dosage and administration

Instill one or two drops into the affected eye(s) every four hours. In severe infections, dosage may be increased to as much as two drops once every hour.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Gentamicin Sulfate is a water-soluble antibiotic of the aminoglycoside group. Gentamicin Sulfate Ophthalmic Solution is a sterile, aqueous solution buffered to approximately pH 7 for ophthalmic use. Gentamicin is obtained from cultures of Micromonospora purpurea. It is a mixture of the sulfate salts of gentamicin C 1, C 2, and C 1A. All three components appear to have similar antimicrobial activities. Gentamicin sulfate occurs as white powder and is soluble in water and insoluble in alcohol. The structure is as follows:

chemicalstructure
chemicalstructure

Established name: Gentamicin Sulfate

Chemical name: 0-3-Deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)-0-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyl-(1→4)]-2-deoxy-D-streptamine.

Ingredients: Each mL contains: Active: Gentamicin Sulfate USP (equivalent to 3 mg gentamicin). Preservative: Benzalkonium Chloride 0.1 mg (0.01%). Inactives: Sodium Chloride, Dried Sodium Phosphate, Tyloxapol, Sodium Hydroxide and/or Hydrochloric Acid (to adjust pH) and Purified Water.                        

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Microbiology: Gentamicin sulfate is active in vitro against many strains of the following microorganisms:

Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Gentamicin Sulfate Ophthalmic Solution is indicated in the topical treatment of ocular bacterial infections, including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Gentamicin Sulfate Ophthalmic Solution is contraindicated in patients with known hypersensitivity to any of the components.

WARNINGS

WARNINGS SECTION

NOT FOR INJECTION INTO THE EYE. Gentamicin Sulfate Ophthalmic Solution is not for injection. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.

PRECAUTIONS

PRECAUTIONS SECTION

General

Prolonged use of topical antibiotics may give rise to overgrowth of non-susceptible organisms including fungi. Bacterial resistance to gentamicin may also develop. If purulent discharge, inflammation or pain becomes aggravated, the patient should discontinue use of the medication and consult a physician. If irritation or hypersensitivity to any component of the drug develops, the patient should discontinue use of this preparation, and appropriate therapy should be instituted.

Information for Patients

INFORMATION FOR PATIENTS SECTION

To avoid contamination, do not touch tip of container to the eye, eyelid, or any surface.

Repackaged By / Distributed By: RemedyRepack Inc.

625 Kolter Drive, Indiana, PA 15701

(724) 465-8762

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

There are no published carcinogenicity or impairment of fertility studies on gentamicin. Aminoglycoside antibiotics have been found to be non-mutagenic.

Pregnancy

PREGNANCY SECTION

Pregnancy Category C.Gentamicin has been shown to depress body weights, kidney weights, and median glomerular counts in newborn rats when administered systemically to pregnant rats in daily doses approximately 500 times the maximum recommended ophthalmic human dose. There are no adequate and well-controlled studies in pregnant women. Gentamicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in neonates have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations. The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects, and conjunctival hyperemia. Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura, and hallucinations.

To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Instill one or two drops into the affected eye(s) every four hours. In severe infections, dosage may be increased to as much as two drops once every hour.

HOW SUPPLIED

HOW SUPPLIED SECTION

Gentamicin Sulfate Ophthalmic Solution: 5 mL in plastic dispenser.

NDC: 70518-1323-00

PACKAGING: 5 mL in 1 BOTTLE PLASTIC TYPE 0

STORAGE

Protect from light and store away from heat. Store at controlled room temperature 15° to 25°C (59° to 77°F).

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

SPL UNCLASSIFIED SECTION

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DRUG: Gentamicin Sulfate

GENERIC: Gentamicin Sulfate

DOSAGE: SOLUTION

ADMINSTRATION: OPHTHALMIC

NDC: 70518-1323-0

PACKAGING: 5 mL in 1 BOTTLE, PLASTIC

ACTIVE INGREDIENT(S):

  • GENTAMICIN SULFATE 3mg in 1mL

INACTIVE INGREDIENT(S):

  • BENZALKONIUM CHLORIDE
  • SODIUM CHLORIDE
  • SODIUM PHOSPHATE
  • TYLOXAPOL
  • SODIUM HYDROXIDE
  • HYDROCHLORIC ACID
  • WATER

MM1MM1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61314-633-05ML - Milliliter61314-6337f3d9c77-40cf-4ab8-9b40-b966eba6104712012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70518-132370518-1323-0
61314-633

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062196-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062196-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062196-001GENTAMICIN SULFATEEQ 0.3% BASESOLUTION/DROPS / OPHTHALMICATApproved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A062196-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A062196-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062196-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062196-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062196-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062196-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062196-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062196-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062196-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062196-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062196-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062196-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062196-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062196-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062196-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062196-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062196-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062196-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062196-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062196-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062196-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062196-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062196-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A062196-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062196-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062196-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062196-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A062196-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062196-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062196-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062196-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062196-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062196-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062196-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062196-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062196-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062196-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062196-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062196-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062196-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
214e0668-c48c-a019-e063-6394a90ac5ecd1d01dd5-08e7-410f-994e-9fcdecccbe2f2024-09-04Warnings, Adverse reactionsExact identifier
spl set id: d1d01dd5-08e7-410f-994e-9fcdecccbe2f
Gentamicin SulfateGENTAMICIN SULFATESandoz Inca213fb9c-08ea-4f30-a6c9-93c7a9ba52802024-01-02Warnings, Adverse reactionsExact identifier
ndc (product): 61314-633

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.